Health Care

Noticeable Healthcare Stock Highlights: Medivation, Inc. (NASDAQ:MDVN)

0

Medivation, Inc. (NASDAQ:MDVN) closed its last session at $81.12 with the change of +0.20%. The market capitalization of the company is $13.46B with an average Volume of 3.79 million shares. The stock currently has its 52-Week High range of $81.15 and 52-week low range of $26.41. The Price to Book (P/B) ratio stands at 25.11. The stock traded total quantity of 5.9 million shares.

Currently Medivation, Inc. (MDVN) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “2″ Analysts”. “0” rated “Sell” for the company. “14” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $78.36 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $82.00 however minimum price target advised by analysts is $64.00. The Median price target for the stock is measured at $81.50.

Presently, Analysts decided consensus EPS estimate of $0.30 for present quarter and one month ago projected EPS estimate was at $0.30. If we take a look at back 3 month ago, consensus EPS estimate was $0.33.

A current consensus EPS estimate for next quarter is at $0.42 and 3 month ago EPS forecast was $0.42. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.41.

For current fiscal year, most recent EPS estimate is set at $-1.66 based on Analyst consensus and three month ago consensus EPS opinions was at $1.03. During period one month ago, consensus EPS forecast was decided at $-1.67.

A current consensus EPS projection for next fiscal year is observed at $1.82 and one month ago consensus EPS forecast was at $1.82. Take a look at back three month ago, consensus EPS estimate opinions was decided at $1.76 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 10 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 7 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 11 said a “Buy Rating” and 0 announced “Overweight Rating”. 6 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter